These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36815647)

  • 21. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance.
    Sadr S; Ahmadi Simab P; Niazi M; Yousefsani Z; Lotfalizadeh N; Hajjafari A; Borji H
    Expert Rev Anti Infect Ther; 2024 Jun; 22(6):435-451. PubMed ID: 38804866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance in parasites: can we stay ahead of the evolutionary curve?
    Sibley CH; Hunt SY
    Trends Parasitol; 2003 Nov; 19(11):532-7. PubMed ID: 14580966
    [No Abstract]   [Full Text] [Related]  

  • 23. The diverse roles of cysteine proteases in parasites and their suitability as drug targets.
    McKerrow JH
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0005639. PubMed ID: 30138311
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antiparasitic drugs. Review of the useful drugs in the treatment of classic and emergent parasitic diseases].
    Pérez JL; Carranza C; Mateos F
    Rev Esp Quimioter; 2009 Jun; 22(2):93-105. PubMed ID: 19544101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the traditional use of southern African medicinal plants for the treatment of selected parasite infections affecting humans.
    Cock IE; Selesho MI; Van Vuuren SF
    J Ethnopharmacol; 2018 Jun; 220():250-264. PubMed ID: 29621583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aromatic diamidines as antiparasitic agents.
    Soeiro MN; De Souza EM; Stephens CE; Boykin DW
    Expert Opin Investig Drugs; 2005 Aug; 14(8):957-72. PubMed ID: 16050790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery.
    Jain V; Sharma A; Singh G; Yogavel M; Sharma A
    ACS Infect Dis; 2017 Apr; 3(4):281-292. PubMed ID: 28195698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review.
    Mercan DA; Niculescu AG; Grumezescu AM
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Current Directions of Searching for Antiparasitic Drugs.
    Dziduch K; Greniuk D; Wujec M
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heme metabolism as a therapeutic target against protozoan parasites.
    Lechuga GC; Pereira MCS; Bourguignon SC
    J Drug Target; 2019 Aug; 27(7):767-779. PubMed ID: 30332897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
    Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
    Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS.
    Gondim BLC; da Silva Catarino J; de Sousa MAD; de Oliveira Silva M; Lemes MR; de Carvalho-Costa TM; de Lima Nascimento TR; Machado JR; Rodrigues V; Oliveira CJF; Cançado Castellano LR; da Silva MV
    Curr Pharm Des; 2019; 25(37):3983-3996. PubMed ID: 31612822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding Bromodomain Targeting into Neglected Parasitic Diseases.
    Tallant C; Bamborough P; Chung CW; Gamo FJ; Kirkpatrick R; Larminie C; Martín J; Prinjha R; Rioja I; Simola DF; Gabarró R; Calderón F
    ACS Infect Dis; 2021 Nov; 7(11):2953-2958. PubMed ID: 34612618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-parasitic activity of polyether ionophores.
    Antoszczak M; Steverding D; Huczyński A
    Eur J Med Chem; 2019 Mar; 166():32-47. PubMed ID: 30684869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tropical and Subtropical Parasitic Diseases: Targets for a New Approach to Virtual Screening.
    Yunta MJR; Dietrich RC
    Mol Inform; 2019 Nov; 38(11-12):e1900052. PubMed ID: 31490642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications.
    Uddin I; Venkatachalam S; Mukhopadhyay A; Usmani MA
    Curr Pharm Des; 2016; 22(11):1472-84. PubMed ID: 26775674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Innovation in antiparasitic agents].
    Gayral P; Peters W
    Ann Parasitol Hum Comp; 1991; 66 Suppl 1():61-3. PubMed ID: 1805679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.